Jeito Capital
Portfolio in Switzerland · Netherlands: 3 funded startups tracked by Uback, 3 of them in a ranking.
Portfolio on Uback3startups, 2 countries
In a ranking3ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedMay 2025ReproNovo
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Noema Pharma | #13 Switzerland | Biotech › CNS drugs | Series B (incl. extension) · USD 150M · Dec 2024 | Hundreds of M$ |
| Azafaros | #15 Netherlands | Biotech › rare diseases | Series B · USD 150M · May 2025 | Hundreds of M$ |
| ReproNovo | #33 Switzerland | Biotech › women's health | Series A · USD 65M · May 2025 | Hundreds of M$ |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12024
22025
Co-investors
Forbion · EQT Life Sciences · AXA IM Alts · M Ventures · Forbion Growth
Investors that joined the same rounds, as reported by public sources.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.